NEW YORK (GenomeWeb) – Roche announced today that it has received approval from the US Food and Drug Administration for its Cobas MPX test, a nucleic acid test for the detection of HIV, hepatitis B, and hepatitis C in human blood plasma and serum.

The assay, which is approved for use on the company's Cobas 6800 and 8800 systems, allows screening labs in the US to use advanced PCR-based diagnostic technology to screen donated blood and plasma, to prevent the spread of HIV-1 and HIV-2, HBV, and HCV through transfused blood products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.